Medical Advisor to the Board

Update Dr Gary Deed had to withdraw from the Advisor role from ME Group Australia effectively on 3 December 2024 due to his upcoming work commitment We would like to express our gratitude for his support for our purpose, and wish him all the best for the new role. === We are delighted to welcome… Continue reading Medical Advisor to the Board

Occupational Therapy Advisor to the Board

We are delighted to welcome Julie Hughes to our Occupational Therapy Advisor to the Board. We hope to strengthen knowledge and capacity of our future clinic with her guidance. The role of Occupational Therapy is to assist people to participate in everyday life, the things they want to do, need to do, or are expected… Continue reading Occupational Therapy Advisor to the Board

Research Advisor to the Board

We are excited to welcome Dr Natalie Eaton-Fitch (PhD) to our Research Advisor to the Board. Natalie is a Research Fellow at the National Centre for Neuroimmunology and Emerging Diseases (NCNED), Griffith University. She holds a multidisciplinary PhD in Immunology and Epidemiology in the field of ME/CFS. Natalie’s research at the NCNED has been instrumental… Continue reading Research Advisor to the Board

MRI and Neuroimaging Research Advisor to the Board

We are excited to welcome Dr Kiran Thapaliya (PhD) to our team. Kiran has accepted to be our Neuroimaging Research Advisor to the Board.

His expertise will strengthen the evidence on neurological abnormalities with ME-ICC. It will help us to create Clinical Pathway for ME and Neuroimaging protocol for clinicians.

Knowledge Translation and Research Advisor to the Board

We are excited to welcome Dr Maria Alejandra Pinero de Plaza (PhD) to our team! Alejandra has accepted to be our Knowledge Translation and Research Advisor to the Board. Alejandra is a scientist committed to facilitating healthy living and better public health services through knowledge translation and health research. She is a Research Fellow at… Continue reading Knowledge Translation and Research Advisor to the Board